MG
CLBT icon

Marex Group’s Cellebrite CLBT Stock Holding History

Marex Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,379
Closed -$602K – 1055
2025
Q4 		$602K Buy
+33,379
New +$599K ﹤0.01% 510
2025
Q2 		– Sell
-13,000
Closed -$253K – 701
2025
Q1 		$253K Hold
13,000
– – ﹤0.01% 507
2024
Q4 		$286K Hold
13,000
– – ﹤0.01% 459
2024
Q3 		$219K Hold
13,000
– – 0.01% 456
2024
Q2 		$155K Hold
13,000
– – ﹤0.01% 535
2024
Q1 		$144K Buy
+13,000
New +$133K ﹤0.01% 410

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marex Group's CLBT Position: Q1 2026 in Review

Marex Group sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 33,379 shares — an estimated $602K sold.

Marex Group first reported a position in CLBT in Q1 2024 and held it in 6 quarters. The position peaked at $602K in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Marex Group reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 33,379 Cellebrite shares in Q1 2026, an estimated $602K.
  • Marex Group first reported a position in Cellebrite in Q1 2024 and held it in 6 quarters.
  • Marex Group's Cellebrite position peaked at $602K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.